|
[1]
|
Fortún J, Navas E. Latent tuberculosis infection: approach and therapeutic schemes. Rev Esp Quimioter 2022;35 Suppl 3(Suppl 3):94-6. http://dx.doi.org/10.37201/req/s03.20.2022. |
|
[2]
|
Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 2016;13(10):e1002152. https://doi.org/10.1371/journal.pmed.1002152CrossRef
|
|
[3]
|
Rodriguez-Morales AJ, Abbara A, Ntoumi F, Kapata N, Mwaba P, Yeboah-Manu D, et al. World tuberculosis day 2023 - Reflections on the spread of drug-resistant tuberculosis by travellers and reducing risk in forcibly displaced populations. Travel Med Infect Dis 2023;53:102568. https://doi.org/10.1016/j.tmaid.2023.102568CrossRef
|
|
[4]
|
Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK. Partitioning linear trends in age-adjusted rates. Cancer Causes Control. 2000;11(1):31 − 35 https://doi.org/10.1023/a:1008953201688CrossRef
|
|
[5]
|
Hoy D, Kienene T, Reiher B, Roth A, Tira T, McKenzie J, Merilles OEA, Viney K. Battling tuberculosis in an island context with a high burden of communicable and non-communicable diseases: epidemiology, progress, and lessons learned in Kiribati, 2000 to 2012. Int J Infect Dis. 2015;30:135 − 141 https://doi.org/10.1016/j.ijid.2014.11.025CrossRef
|
|
[6]
|
Paton NI, Borand L, Benedicto J, Kyi MM, Mahmud AM, Norazmi MN, et al. Diagnosis and management of latent tuberculosis infection in Asia: review of current status and challenges. Int J Infect Dis 2019;87:21 − 9. https://doi.org/10.1016/j.ijid.2019.07.004CrossRef
|
|
[7]
|
Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health 2013;34:271 − 86. https://doi.org/10.1146/annurev-publhealth-031912-114431CrossRef
|
|
[8]
|
Wang YP, Jing WZ, Liu J, Liu M. Global trends, regional differences and age distribution for the incidence of HIV and tuberculosis co-infection from 1990 to 2019: results from the global burden of disease study 2019. Infect Dis (Lond) 2022;54(11):773 − 83. https://doi.org/10.1080/23744235.2022.2092647CrossRef
|
|
[9]
|
Flores GP, Alberto IRI, Eala MAB, Cañal JPA. The social determinants of tuberculosis in the Philippines. Lancet Glob Health 2022;10(1):e38. https://doi.org/10.1016/S2214-109X(21)00516-7CrossRef
|
|
[10]
|
Calderon JS, Perry KE, Thi SS, Stevens LL. Innovating tuberculosis prevention to achieve universal health coverage in the Philippines. Lancet Reg Health West Pac 2022;29:100609. https://doi.org/10.1016/j.lanwpc.2022.100609CrossRef
|